Anticoagulants and thrombolytics during pregnancy

Seminars in Perinatology

Volumn 21, Issue 2, 1997, Pages 149-153

  Ramin, S M ^a   Ramin, K D ^a   Gilstrap, L C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBIN III; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; PROTEIN C; PROTEIN S; STREPTOKINASE; UROKINASE; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLINDNESS; CHEMICAL TERATOGENESIS; CORPUS CALLOSUM AGENESIS; DANDY WALKER SYNDROME; DRUG INDICATION; DRUG SAFETY; FETUS DEATH; FETUS RISK; FETUS WASTAGE; HEARING IMPAIRMENT; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MICROCEPHALY; OSTEOPENIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; THROMBOPHLEBITIS;

EID: 0030902914     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(97)80058-4     Document Type: Article

References (35)

1. (S) Urokinase Pulmonary Embolism Trial A national cooperative study Circulation 47 1973 1 108
2. Sachs BP Brown DAJ Driscoll SG Maternal mortality in Massachusetts: Trends and prevention N Engl J Med 316 1987 667 672
3. Kaunitz AM Hughes JM Grimes DA Causes of maternal mortality in the United States Obstet Gynecol 65 1985 605 612
4. Berg CJ Atrash HK Koonin LM Pregnancy-related mortality in the United States, 1987–1990 Obstet Gynecol 88 1996 161 167
5. Rutherford SE Phelan JP Deep venous thrombosis and pulmonary embolus Clark SL Cotton DB Hankins GDV Critical Care Obstetrics ed 2 1991 Blackwell Scientific Boston, MA 150 179
6. Moser KM Fedullo PF LittleJohn JK Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis JAMA 271 1994 223 225
7. Hall JG Pauli RM Wilson KM Maternal and fetal sequelae of anticoagulation during pregnancy Am J Med 68 1980 122 140
8. Stevenson RE Burton M Ferlauto GJ Hazards of oral anticoagulants during pregnancy JAMA 243 1980 1549 1551
9. (suppl) Ginsberg JS Hirsh J Use of antithrombotic agents during pregnancy Chest 108 1995 305 311
10. Toglia MR Weg JG Venous thromboembolism during pregnancy N Engl J Med 335 1996 108 114
11. Nageotte MP Freeman RK Garite TJ Anticoagulation in pregnancy Am J Obstet Gynecol 141 1981 472 473
12. Ginsberg JS Kowalchuk G Hirsh J Heparin therapy during pregnancy: Risks to the fetus and mother Arch Intern Med 149 1989 2233 2236
13. Fejgin MD Lourwood DL Low molecular weight heparins and their use in obstetrics and gynecology Obstet Gynecol Surv 49 1994 424 431
14. Schneider D Heilmann L Harenberg J Placental transfer of low-molecular weight heparin Geburtshilfe und Frauenheilkunde 55 1995 93 98
15. Omri A Delaloye JF Anderson H LMW heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy Thromb Haemost 61 1989 55 56
16. Gillis S Shushan A Eldor A Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy Int J Gynecol Obstet 39 1992 297 301
17. Dulitzki M Pauzner R Langevitz P Low-molecular-weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies Obstet Gynecol 87 1996 380 383
18. Bertoli D Borelli G Peri- and postnatal teratology and reproductive studies of a low molecular weight heparin in rats Arzneim-Forsch 36 1986 1260 1263
19. Rossoff LJ Diagnosis, treatment, and prevention of venous thromboembolism in women Prim Care Update Obstet Gynecol 1 1994 108 116
20. Warkentin TE Levine MN Hirsh J Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
21. Sturridge F de Sewiet M Letsky E The use of low molecular weight heparin for thromboprophylaxis in pregnancy Br J Obstet Gynaecol 101 1994 69 71
22. Ginsberg JS Kowalchuk G Hirsh J Heparin effect on bone density Thromb Haemost 64 1990 286 289
23. Dahlman TC Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin Am J Obstet Gynecol 168 1993 1265 1270
24. Akutsu T Ito C Sakai K Studies on teratogenicity of urokinase in mice and rats Oyo Yakuri Pharmacometrics 8 1974 981 989
25. Turrentine MA Braems G Ramirez MM Use of thrombolytics for the treatment of thromboembolic disease during pregnancy Obstet Gynecol Surv 50 1995 534 541
26. Markel A Manzo RA Strandness DE Jr The potential role of thrombolytic therapy in venous thrombosis Arch Intern Med 152 1992 1265 1267
27. Cunningham FG MacDonald PC Gant NF Pulmonary disorders ed 19 Williams Obstetrics 1993 Appleton & Lange Norwalk, CT 1111 1118
28. Tengborn L Bergqvist D Matzsch T Recurrent thromboembolism in pregnancy and pueperium: Is there a need for thromboprophylaxis? Am J Obstet Gynecol 160 1989 90 94
29. Badaracco MA Vessey MP Recurrence of venous thromboembolic disease and use of oral contraceptives Br Med J 1 1974 215 217
30. Salazar E Zajarias A Gutierrez N The problem of cardiac valve prostheses, anticoagulants, and pregnancy Circulation 70 suppl 1 1984 169 177
31. Iturbe-Alessio I Fonseca MDC Mutchinick O Risks of anticoagulant therapy in pregnant women with artificial heart valves N Engl J Med 27 1986 1390 1393
32. Salazar E Izaguirre R Verdejo J Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses J Am Coll Cardiol 27 1996 1698 1703
33. Sbarouni E Oakley CM Outcome of pregnancy in women with valve prostheses Br Heart J 71 1994 196 201
34. Lee CN Wu CC Lin PY Pregnancy following cardiac prosthetic valve replacement Obstet Gynecol 83 1994 353 356
35. Cotrufo M de Luca TSL Calabro R Coumarin antico-agulation during pregnancy in patients with mechanical valve prostheses Eur J Cardiothorac Surg 5 1991 300 305